<DOC>
	<DOC>NCT00095043</DOC>
	<brief_summary>The purpose of this trial is to study the safety of MK0928 on insomnia in the elderly.</brief_summary>
	<brief_title>Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)</brief_title>
	<detailed_description>The duration of treatment is 1 year.</detailed_description>
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<criteria>Diagnosis of Insomnia</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>